Discover investment opportunities in Top 30 Stocks Under $5 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $5 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $5 using our Smart AI Filter.
6 stocks found for "Top 30 Stocks Under $5"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.20 | ±100.0% | 0.0 | 0.00% | |||
0.74 | ±35.0% | 3.5 | 5.20% | |||
1.43 | ±73.1% | -7.7 | 0.00% | |||
0.86 | ±55.0% | 41.8 | 0.00% | |||
1.11 | ±75.1% | -18.3 | 0.00% | |||
1.72 | ±100.0% | -11.8 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Major U.S. stock indices rose to new all-time highs last week on the hopes of finally securing a rate cut from the Federal Reserve in September. However, the rally seems much higher than you'd expect from a possible 25-basis-point cut, which is the most the Fed is likely to do next month.
Read moreQ: What are the growth prospects of NIO in the electric vehicle sector?
A: NIO, a notable player in the electric vehicle industry, has shown strong growth potential due to increasing demand for EVs in China. Past expansions into Europe also suggest ambitions to become a global brand. Investors may consider NIO's technology advancements and strategic partnerships as contributing factors to its growth.
Q: Is SRNE a high-risk investment in the biotech sector?
A: Sorrento Therapeutics (SRNE), operating in the biotech sector, often faces volatility due to the speculative nature and regulatory challenges typical of biotech stocks. Historically, R&D outcomes and FDA approvals have significantly impacted its stock price, suggesting a high-risk profile.
Q: How does SNDL's involvement in the cannabis industry affect its stock performance?
A: SNDL, engaged in the cannabis sector, benefits from the growing legalization trend in North America. Cannabis stocks often experience volatility because of regulatory changes and market competition, influencing SNDL's stock performance.
Q: What factors contribute to IDEX's valuation in alternative energy and electric vehicles?
A: Ideanomics (IDEX) focuses on electric vehicles and alternative energy solutions, potentially benefiting from increased demand for sustainable energy. Its valuation may reflect investor sentiment towards green initiatives and future expansion projects.
Q: What risks are associated with investing in NKLA, a hydrogen vehicle manufacturer?
A: Nikola Corporation (NKLA) faces risks typical of early-stage manufacturing companies, including technological challenges, production delays, and reliance on emerging hydrogen technology. Investor confidence can be swayed by contract developments and partnerships.
Q: How has CLOV's position in the health insurance market impacted its stock?
A: Clover Health Investments (CLOV) operates in the insurance sector, where regulatory changes and market competition play significant roles. Recent expansion in healthcare technology might positively affect its market position, although it must manage the pressures of HealthTech innovation.